Daito Pharmaceutical Co.,Ltd.
4577.T · JPX
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Market Cap | ¥37 | ¥30 | ¥15 | ¥16 |
| - Cash | ¥2 | ¥2 | ¥2 | ¥3 |
| + Debt | ¥12 | ¥12 | ¥10 | ¥11 |
| Enterprise Value | ¥47 | ¥40 | ¥24 | ¥24 |
| Revenue | ¥13 | ¥14 | ¥12 | ¥12 |
| % Growth | -7.3% | 16.7% | 1% | – |
| Gross Profit | ¥3 | ¥2 | ¥2 | ¥2 |
| % Margin | 19.7% | 16.1% | 16.6% | 17.9% |
| EBITDA | ¥2 | ¥2 | ¥2 | ¥2 |
| % Margin | 16% | 12.1% | 13.9% | 14.1% |
| Net Income | ¥1 | ¥1 | ¥0 | ¥0 |
| % Margin | 5.3% | 4.9% | 2.6% | 2.4% |
| EPS Diluted | 23.21 | 22.71 | 20.33 | 18.96 |
| % Growth | 2.2% | 11.7% | 7.2% | – |
| Operating Cash Flow | ¥0 | ¥0 | ¥0 | ¥1 |
| Capital Expenditures | ¥0 | ¥0 | ¥0 | -¥2 |
| Free Cash Flow | ¥0 | ¥0 | ¥0 | -¥2 |